Francisco, Merlindo M.

HRN: 28-75-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2026
CEFTAZIDIME 1GM (VIAL)
03/27/2026
04/02/2026
IV
2g
Q8
CAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: